Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

NCS Multistage Holdings (NCSM) Research & Development (2024 - 2025)

NCS Multistage Holdings (NCSM) has 2 years of Research & Development data on record, last reported at $612000.0 in Q4 2025.

  • For Q4 2025, Research & Development rose 15.25% year-over-year to $612000.0; the TTM value through Dec 2025 reached $2.4 million, up 15.89%, while the annual FY2025 figure was $2.4 million, 15.89% up from the prior year.
  • Research & Development reached $612000.0 in Q4 2025 per NCSM's latest filing, down from $656000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $656000.0 in Q3 2025 and bottomed at $501000.0 in Q2 2024.